Diagnostic tests for Cushing's syndrome differ from published guidelines: Data from ERCUSYN

Elena Valassi; Holger Franz; Thierry Brue; Richard A. Feelders; Romana Netea-Maier; Stylianos Tsagarakis; Susan M. Webb; Maria Yaneva; Martin Reincke; Michael Droste; Irina Komerdus; Dominique Maiter; Darko Kastelan; Philippe Chanson; Marija Pfeifer; Christian J. Strasburger; Miklós Tóth; Olivier Chabre; Antoine Tabarin; Michal Krsek; Carmen Fajardo; Marek Bolanowski; Alicia Santos; John A.H. Wass; Peter J. Trainer; A. Ambrogio; G. Aranda; M. Arosio; M. Balomenaki; P. Beck-Peccoz; C. Berr-Kirmair; J. Bollerslev; D. Carvalho; F. Cavagnini; E. Christ; F. Demtröder; J. Denes; C. Dimopoulou; A. Dreval; T. Dusek; E. Erdinc; J. A. Evang; J. Fazel; S. Fica; E. Ghigo; M. Goth; Y. Greenman; V. Greisa; I. Halperin; F. A. Hanzu; A. Hermus; G. Johannsson; P. Kamenicky; A. Kasperlik-Zaluska; J. Kirchner; I. Kraljevic; A. Kruszynska; I. Lambrescu; S. Lang; A. Luger; N. Marpole; S. Martin; M. Martinie; O. Moros; J. Newell-Price; M. Orbetzova; I. Paiva; F. Pecori Giraldi; A. M. Pereira; J. Pickel; V. Pirags; O. Ragnarsson; A. D. Reghina; P. Riesgo; M. Roberts; S. Roerink; O. Roig; C. Rowan; P. Rudenko; M. A. Sahnoun; J. Salvador; H. A. Sigurjonsdottir; T. Skoric Polovina; R. Smith; B. Stachowska; G. Stalla; J. Tóke; E. Ubina; S. Vinay; M. Wagenmakers; S. Werner; J. Young; P. Zdunowski; K. Zopf; S. Zopp; I. Zosin

doi:10.1530/EJE-16-0967

Diagnostic tests for Cushing's syndrome differ from published guidelines: Data from ERCUSYN

Elena Valassi, Holger Franz, Thierry Brue, Richard A. Feelders, Romana Netea-Maier, Stylianos Tsagarakis, Susan M. Webb, Maria Yaneva, Martin Reincke, Michael Droste, Irina Komerdus, Dominique Maiter, Darko Kastelan, Philippe Chanson, Marija Pfeifer, Christian J. Strasburger, Miklós Tóth, Olivier Chabre, Antoine Tabarin, Michal KrsekCarmen Fajardo, Marek Bolanowski, Alicia Santos, John A.H. Wass, Peter J. Trainer, A. Ambrogio, G. Aranda, M. Arosio, M. Balomenaki, P. Beck-Peccoz, C. Berr-Kirmair, J. Bollerslev, D. Carvalho, F. Cavagnini, E. Christ, F. Demtröder, J. Denes, C. Dimopoulou, A. Dreval, T. Dusek, E. Erdinc, J. A. Evang, J. Fazel, S. Fica, E. Ghigo, M. Goth, Y. Greenman, V. Greisa, I. Halperin, F. A. Hanzu, A. Hermus, G. Johannsson, P. Kamenicky, A. Kasperlik-Zaluska, J. Kirchner, I. Kraljevic, A. Kruszynska, I. Lambrescu, S. Lang, A. Luger, N. Marpole, S. Martin, M. Martinie, O. Moros, J. Newell-Price, M. Orbetzova, I. Paiva, F. Pecori Giraldi, A. M. Pereira, J. Pickel, V. Pirags, O. Ragnarsson, A. D. Reghina, P. Riesgo, M. Roberts, S. Roerink, O. Roig, C. Rowan, P. Rudenko, M. A. Sahnoun, J. Salvador, H. A. Sigurjonsdottir, T. Skoric Polovina, R. Smith, B. Stachowska, G. Stalla, J. Tóke, E. Ubina, S. Vinay, M. Wagenmakers, S. Werner, J. Young, P. Zdunowski, K. Zopf, S. Zopp, I. Zosin

Department of Medicine

Research output: Contribution to journal › Review article › Research › peer-review

43 Citations (Scopus)

Abstract

© 2017 European Society of Endocrinology Printed in Great Britain. Objective: To evaluate which tests are performed to diagnose hypercortisolism in patients included in the European Registry on Cushing's syndrome (ERCUSYN), and to examine if their use differs from the current guidelines. Patients and methods: We analyzed data on the diagnostic tests performed in 1341 patients with Cushing's syndrome (CS) who have been entered into the ERCUSYN database between January 1, 2000 and January 31, 2016 from 57 centers in 26 European countries. Sixty-seven percent had pituitary-dependent CS (PIT-CS), 24% had adrenaldependent CS (ADR-CS), 6% had CS from an ectopic source (ECT-CS) and 3% were classified as having CS from other causes (OTH-CS). Results: Of the first-line tests, urinary free cortisol (UFC) test was performed in 78% of patients, overnight 1 mg dexamethasone suppression test (DST) in 60% and late-night salivary cortisol (LSaC) in 25%. Use of LSaC increased in the last five years as compared with previous years (P < 0.01). Use of HDDST was slightly more frequent in the last 5 years as compared with previous years (P < 0.05). Of the additional tests, late-night serum cortisol (LSeC) was measured in 62% and 48-h 2 mg/day low-dose dexamethasone suppression test (LDDST) in 33% of cases. ACTH was performed in 78% of patients. LSeC and overnight 1 mg DST supported the diagnosis of both PIT-CS and ADR-CS more frequently than UFC (P < 0.05).

Original language	English
Pages (from-to)	613-624
Journal	European Journal of Endocrinology
Volume	176
Issue number	5
DOIs	https://doi.org/10.1530/EJE-16-0967
Publication status	Published - 1 May 2017

Access to Document

10.1530/EJE-16-0967

Cite this

Valassi, E., Franz, H., Brue, T., Feelders, R. A., Netea-Maier, R., Tsagarakis, S., Webb, S. M., Yaneva, M., Reincke, M., Droste, M., Komerdus, I., Maiter, D., Kastelan, D., Chanson, P., Pfeifer, M., Strasburger, C. J., Tóth, M., Chabre, O., Tabarin, A., ... Zosin, I. (2017). Diagnostic tests for Cushing's syndrome differ from published guidelines: Data from ERCUSYN. European Journal of Endocrinology, 176(5), 613-624. https://doi.org/10.1530/EJE-16-0967

@article{99c7bcd40cb346d0a6348308a5d620c6,

title = "Diagnostic tests for Cushing's syndrome differ from published guidelines: Data from ERCUSYN",

abstract = "{\textcopyright} 2017 European Society of Endocrinology Printed in Great Britain. Objective: To evaluate which tests are performed to diagnose hypercortisolism in patients included in the European Registry on Cushing's syndrome (ERCUSYN), and to examine if their use differs from the current guidelines. Patients and methods: We analyzed data on the diagnostic tests performed in 1341 patients with Cushing's syndrome (CS) who have been entered into the ERCUSYN database between January 1, 2000 and January 31, 2016 from 57 centers in 26 European countries. Sixty-seven percent had pituitary-dependent CS (PIT-CS), 24% had adrenaldependent CS (ADR-CS), 6% had CS from an ectopic source (ECT-CS) and 3% were classified as having CS from other causes (OTH-CS). Results: Of the first-line tests, urinary free cortisol (UFC) test was performed in 78% of patients, overnight 1 mg dexamethasone suppression test (DST) in 60% and late-night salivary cortisol (LSaC) in 25%. Use of LSaC increased in the last five years as compared with previous years (P < 0.01). Use of HDDST was slightly more frequent in the last 5 years as compared with previous years (P < 0.05). Of the additional tests, late-night serum cortisol (LSeC) was measured in 62% and 48-h 2 mg/day low-dose dexamethasone suppression test (LDDST) in 33% of cases. ACTH was performed in 78% of patients. LSeC and overnight 1 mg DST supported the diagnosis of both PIT-CS and ADR-CS more frequently than UFC (P < 0.05).",

author = "Elena Valassi and Holger Franz and Thierry Brue and Feelders, {Richard A.} and Romana Netea-Maier and Stylianos Tsagarakis and Webb, {Susan M.} and Maria Yaneva and Martin Reincke and Michael Droste and Irina Komerdus and Dominique Maiter and Darko Kastelan and Philippe Chanson and Marija Pfeifer and Strasburger, {Christian J.} and Mikl{\'o}s T{\'o}th and Olivier Chabre and Antoine Tabarin and Michal Krsek and Carmen Fajardo and Marek Bolanowski and Alicia Santos and Wass, {John A.H.} and Trainer, {Peter J.} and A. Ambrogio and G. Aranda and M. Arosio and M. Balomenaki and P. Beck-Peccoz and C. Berr-Kirmair and J. Bollerslev and D. Carvalho and F. Cavagnini and E. Christ and F. Demtr{\"o}der and J. Denes and C. Dimopoulou and A. Dreval and T. Dusek and E. Erdinc and Evang, {J. A.} and J. Fazel and S. Fica and E. Ghigo and M. Goth and Y. Greenman and V. Greisa and I. Halperin and Hanzu, {F. A.} and A. Hermus and G. Johannsson and P. Kamenicky and A. Kasperlik-Zaluska and J. Kirchner and I. Kraljevic and A. Kruszynska and I. Lambrescu and S. Lang and A. Luger and N. Marpole and S. Martin and M. Martinie and O. Moros and J. Newell-Price and M. Orbetzova and I. Paiva and Giraldi, {F. Pecori} and Pereira, {A. M.} and J. Pickel and V. Pirags and O. Ragnarsson and Reghina, {A. D.} and P. Riesgo and M. Roberts and S. Roerink and O. Roig and C. Rowan and P. Rudenko and Sahnoun, {M. A.} and J. Salvador and Sigurjonsdottir, {H. A.} and Polovina, {T. Skoric} and R. Smith and B. Stachowska and G. Stalla and J. T{\'o}ke and E. Ubina and S. Vinay and M. Wagenmakers and S. Werner and J. Young and P. Zdunowski and K. Zopf and S. Zopp and I. Zosin",

year = "2017",

month = may,

day = "1",

doi = "10.1530/EJE-16-0967",

language = "English",

volume = "176",

pages = "613--624",

number = "5",

}

Valassi, E, Franz, H, Brue, T, Feelders, RA, Netea-Maier, R, Tsagarakis, S, Webb, SM, Yaneva, M, Reincke, M, Droste, M, Komerdus, I, Maiter, D, Kastelan, D, Chanson, P, Pfeifer, M, Strasburger, CJ, Tóth, M, Chabre, O, Tabarin, A, Krsek, M, Fajardo, C, Bolanowski, M, Santos, A, Wass, JAH, Trainer, PJ, Ambrogio, A, Aranda, G, Arosio, M, Balomenaki, M, Beck-Peccoz, P, Berr-Kirmair, C, Bollerslev, J, Carvalho, D, Cavagnini, F, Christ, E, Demtröder, F, Denes, J, Dimopoulou, C, Dreval, A, Dusek, T, Erdinc, E, Evang, JA, Fazel, J, Fica, S, Ghigo, E, Goth, M, Greenman, Y, Greisa, V, Halperin, I, Hanzu, FA, Hermus, A, Johannsson, G, Kamenicky, P, Kasperlik-Zaluska, A, Kirchner, J, Kraljevic, I, Kruszynska, A, Lambrescu, I, Lang, S, Luger, A, Marpole, N, Martin, S, Martinie, M, Moros, O, Newell-Price, J, Orbetzova, M, Paiva, I, Giraldi, FP, Pereira, AM, Pickel, J, Pirags, V, Ragnarsson, O, Reghina, AD, Riesgo, P, Roberts, M, Roerink, S, Roig, O, Rowan, C, Rudenko, P, Sahnoun, MA, Salvador, J, Sigurjonsdottir, HA, Polovina, TS, Smith, R, Stachowska, B, Stalla, G, Tóke, J, Ubina, E, Vinay, S, Wagenmakers, M, Werner, S, Young, J, Zdunowski, P, Zopf, K, Zopp, S & Zosin, I 2017, 'Diagnostic tests for Cushing's syndrome differ from published guidelines: Data from ERCUSYN', European Journal of Endocrinology, vol. 176, no. 5, pp. 613-624. https://doi.org/10.1530/EJE-16-0967

TY - JOUR

T1 - Diagnostic tests for Cushing's syndrome differ from published guidelines: Data from ERCUSYN

AU - Valassi, Elena

AU - Franz, Holger

AU - Brue, Thierry

AU - Feelders, Richard A.

AU - Netea-Maier, Romana

AU - Tsagarakis, Stylianos

AU - Webb, Susan M.

AU - Yaneva, Maria

AU - Reincke, Martin

AU - Droste, Michael

AU - Komerdus, Irina

AU - Maiter, Dominique

AU - Kastelan, Darko

AU - Chanson, Philippe

AU - Pfeifer, Marija

AU - Strasburger, Christian J.

AU - Tóth, Miklós

AU - Chabre, Olivier

AU - Tabarin, Antoine

AU - Krsek, Michal

AU - Fajardo, Carmen

AU - Bolanowski, Marek

AU - Santos, Alicia

AU - Wass, John A.H.

AU - Trainer, Peter J.

AU - Ambrogio, A.

AU - Aranda, G.

AU - Arosio, M.

AU - Balomenaki, M.

AU - Beck-Peccoz, P.

AU - Berr-Kirmair, C.

AU - Bollerslev, J.

AU - Carvalho, D.

AU - Cavagnini, F.

AU - Christ, E.

AU - Demtröder, F.

AU - Denes, J.

AU - Dimopoulou, C.

AU - Dreval, A.

AU - Dusek, T.

AU - Erdinc, E.

AU - Evang, J. A.

AU - Fazel, J.

AU - Fica, S.

AU - Ghigo, E.

AU - Goth, M.

AU - Greenman, Y.

AU - Greisa, V.

AU - Halperin, I.

AU - Hanzu, F. A.

AU - Hermus, A.

AU - Johannsson, G.

AU - Kamenicky, P.

AU - Kasperlik-Zaluska, A.

AU - Kirchner, J.

AU - Kraljevic, I.

AU - Kruszynska, A.

AU - Lambrescu, I.

AU - Lang, S.

AU - Luger, A.

AU - Marpole, N.

AU - Martin, S.

AU - Martinie, M.

AU - Moros, O.

AU - Newell-Price, J.

AU - Orbetzova, M.

AU - Paiva, I.

AU - Giraldi, F. Pecori

AU - Pereira, A. M.

AU - Pickel, J.

AU - Pirags, V.

AU - Ragnarsson, O.

AU - Reghina, A. D.

AU - Riesgo, P.

AU - Roberts, M.

AU - Roerink, S.

AU - Roig, O.

AU - Rowan, C.

AU - Rudenko, P.

AU - Sahnoun, M. A.

AU - Salvador, J.

AU - Sigurjonsdottir, H. A.

AU - Polovina, T. Skoric

AU - Smith, R.

AU - Stachowska, B.

AU - Stalla, G.

AU - Tóke, J.

AU - Ubina, E.

AU - Vinay, S.

AU - Wagenmakers, M.

AU - Werner, S.

AU - Young, J.

AU - Zdunowski, P.

AU - Zopf, K.

AU - Zopp, S.

AU - Zosin, I.

PY - 2017/5/1

Y1 - 2017/5/1

N2 - © 2017 European Society of Endocrinology Printed in Great Britain. Objective: To evaluate which tests are performed to diagnose hypercortisolism in patients included in the European Registry on Cushing's syndrome (ERCUSYN), and to examine if their use differs from the current guidelines. Patients and methods: We analyzed data on the diagnostic tests performed in 1341 patients with Cushing's syndrome (CS) who have been entered into the ERCUSYN database between January 1, 2000 and January 31, 2016 from 57 centers in 26 European countries. Sixty-seven percent had pituitary-dependent CS (PIT-CS), 24% had adrenaldependent CS (ADR-CS), 6% had CS from an ectopic source (ECT-CS) and 3% were classified as having CS from other causes (OTH-CS). Results: Of the first-line tests, urinary free cortisol (UFC) test was performed in 78% of patients, overnight 1 mg dexamethasone suppression test (DST) in 60% and late-night salivary cortisol (LSaC) in 25%. Use of LSaC increased in the last five years as compared with previous years (P < 0.01). Use of HDDST was slightly more frequent in the last 5 years as compared with previous years (P < 0.05). Of the additional tests, late-night serum cortisol (LSeC) was measured in 62% and 48-h 2 mg/day low-dose dexamethasone suppression test (LDDST) in 33% of cases. ACTH was performed in 78% of patients. LSeC and overnight 1 mg DST supported the diagnosis of both PIT-CS and ADR-CS more frequently than UFC (P < 0.05).

AB - © 2017 European Society of Endocrinology Printed in Great Britain. Objective: To evaluate which tests are performed to diagnose hypercortisolism in patients included in the European Registry on Cushing's syndrome (ERCUSYN), and to examine if their use differs from the current guidelines. Patients and methods: We analyzed data on the diagnostic tests performed in 1341 patients with Cushing's syndrome (CS) who have been entered into the ERCUSYN database between January 1, 2000 and January 31, 2016 from 57 centers in 26 European countries. Sixty-seven percent had pituitary-dependent CS (PIT-CS), 24% had adrenaldependent CS (ADR-CS), 6% had CS from an ectopic source (ECT-CS) and 3% were classified as having CS from other causes (OTH-CS). Results: Of the first-line tests, urinary free cortisol (UFC) test was performed in 78% of patients, overnight 1 mg dexamethasone suppression test (DST) in 60% and late-night salivary cortisol (LSaC) in 25%. Use of LSaC increased in the last five years as compared with previous years (P < 0.01). Use of HDDST was slightly more frequent in the last 5 years as compared with previous years (P < 0.05). Of the additional tests, late-night serum cortisol (LSeC) was measured in 62% and 48-h 2 mg/day low-dose dexamethasone suppression test (LDDST) in 33% of cases. ACTH was performed in 78% of patients. LSeC and overnight 1 mg DST supported the diagnosis of both PIT-CS and ADR-CS more frequently than UFC (P < 0.05).

U2 - 10.1530/EJE-16-0967

DO - 10.1530/EJE-16-0967

M3 - Review article

SN - 0804-4643

VL - 176

SP - 613

EP - 624

JO - European Journal of Endocrinology

JF - European Journal of Endocrinology

IS - 5

ER -

Diagnostic tests for Cushing's syndrome differ from published guidelines: Data from ERCUSYN

Abstract

Access to Document

Fingerprint

Cite this